Skip to main content
. 2021 Apr 1;98(2):E222–E234. doi: 10.1002/ccd.29674

TABLE 6.

In‐hospital outcomes stratified by timing of insertion of Impella 2.5 and CP in relation to the interventional procedure in patients with high‐risk PCI

Combined (N = 174) Before (N = 117) During/after (N = 57) p‐value
In‐hospital outcomes
Death 6%10 3%3 12%7 .02
Life‐threatening or severe bleeding 3%6 1%1 9%5 .02
Number of red blood cell transfusions 2 [1;3] 2 [2;3] 1 [1;2] .20
Device‐related complications 10%17 7%8 16%9 .11
Access‐site bleeding 7%12 4%5 12%7 .06
Limb ischemia 2%4 3%3 2%1 1
Need for endovascular intervention 2%4 3%3 2%1 1
Aortic injury 0% (0) 0% (0) 0% (0) NA
Left ventricular perforation 0% (0) 0% (0) 0% (0) NA
Sepsis 4%7 6%7 0% (0) .10
Acute kidney injurya 13%19 16%14 9%5 .31
Need for renal replacement therapy 4%6 3%3 5%3 .39
Escalation therapyb 0% (0) 0% (0) 0% (0) NA
LVEF at discharge, % 32 [26;40] 33 [26;40] 30 [25;36] .23

Note: In‐hospital outcomes are reported as n (%) or median (interquartile range) as appropriate. One‐year outcomes are reported as number of events (Kaplan–Meier failure estimate [95% confidence interval]).

Abbreviation: LVEF, left‐ventricular ejection fraction.

a

Defined as a serum creatinine increase ≥0.3 mg/dl from baseline.

b

Defined as the need for extracorporeal membrane oxygenation, other left ventricular assist device implantation or heart transplant.